Profitability
Weight: 20%
F
2
- 5yr Avg ROIC -3.6%
- Operating Margin Trend -182.32 pp/yr
ABCL
AbCellera Biologics Inc.
AlphaQuality composite grade, weighted for stable earnings power businesses.
⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
D-
32
- 5yr Avg ROE -3.0%
- 5yr Share-Count CAGR -1.6%
Growth Quality
Weight: 15%
D-
29
- 5yr Revenue CAGR -33.1%
- 5yr EPS CAGR 4.2%
- Revenue-Growth Years (5) 3/5
Cash Generation
Weight: 15%
D+
43
- 5yr FCF Margin -221.5%
- 5yr FCF/NI Conversion 1.25x
Balance Sheet
Weight: 20%
C-
50
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score 3.06
Stability
Weight: 15%
D-
32
- EPS Volatility (σ/μ) 0.67
- Piotroski F-Score 3
- Negative-Revenue Years (5) 2/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.1 of 2 gurus held; 1 added; 1 full exit.
- Holders
- 1 -1
- Avg Δ position
- +17.7%
- New buys
- 0
- Full exits
- 1